Colinz Laboratories ltd.

BSE: COLINZ531210ISIN INE923C01011

Healthcare
Pharmaceuticals

Share price

₹69.00-0.97 (-1.39%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹87.91
52W low: ₹36.11
Off 52W high: -21.51%
1M return: -5.48%
3M return: -15.54%
6M return: +44.56%
1Y return: +56.00%
20D avg volume: 1,092
50 DMA: ₹71.82
200 DMA: ₹61.86

Key ratios Standalone

Market cap: ₹17.38 Cr
Current price: ₹69.00
52W high / low: ₹87.91 / ₹36.11
Face value: ₹10.00
P/E: 6.24
P/B: 1.86
EPS (TTM): ₹11.05
Book value / share: ₹37.10
ROE: 29.78%
ROCE: 7.40%
Operating margin: 14.32%
Net margin: 8.19%
Debt / equity: 0.04
Net debt: ₹-0.31 Cr
Interest cover: 14.80
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 68.9 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	1.55	1.24	1.75	1.43	1.39	1.57	1.45	1.47	1.86	1.75	—
	0.14	0.12	0.17	0.08	0.16	0.08	0.08	0.08	0.08	0.07	—
	1.69	1.36	1.92	1.51	1.55	1.64	1.53	1.54	1.94	1.81	—
	1.50	1.23	1.71	1.38	1.36	1.48	1.40	1.44	1.73	1.63	—
	0.09	0.11	0.11	0.11	0.16	0.19	0.10	0.17	0.14	0.15	—
	0.39	0.30	0.26	0.26	0.18	0.43	0.27	0.41	0.42	0.35	—
	0.61	0.64	0.69	0.58	0.76	0.66	0.70	0.69	0.73	0.72	—
	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01	—
	0.02	0.04	0.04	0.04	0.04	0.04	0.03	0.03	0.03	0.03	—
	0.28	0.32	0.38	0.28	0.29	0.37	0.15	—	—	—	—
	0.19	0.14	0.22	0.13	0.19	0.16	0.12	0.10	0.21	0.18	—
	0.00	2.76	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.19	2.90	0.22	0.13	0.19	0.16	0.12	0.10	0.21	0.18	—
	0.06	0.50	0.04	0.04	0.05	0.04	-0.03	0.05	0.05	0.05	—
	0.13	2.40	0.17	0.08	0.14	0.12	0.15	0.05	0.16	0.14	—
	0.50	9.53	0.68	0.33	0.56	0.54	0.60	0.21	0.62	0.54	—
Key metrics
	0.23	2.95	0.27	0.18	0.24	0.21	0.17	0.14	0.25	0.22	—
	14.80%	237.90%	15.40%	12.60%	17.30%	13.40%	11.70%	9.50%	13.40%	12.60%	—
	8.40%	193.50%	9.70%	5.60%	10.10%	7.60%	10.30%	3.40%	8.60%	8.00%	—
	1.60%	—	2.30%	—	2.00%	—	1.40%	—	—	—	—
	11.50%	-21.00%	20.70%	-2.70%	-25.30%	-10.30%	—	—	—	—	—
	-7.10%	1,900.00%	13.30%	60.00%	-12.50%	-14.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	5.97	6.14	6.53	—
	0.51	0.48	0.30	—
	6.48	6.62	6.83	—
	5.82	5.93	6.21	—
	0.42	0.57	0.56	—
	1.21	1.12	1.45	—
	2.52	2.70	2.84	—
	0.05	0.05	0.04	—
	0.14	0.16	0.13	—
	1.26	1.32	1.10	—
	0.68	0.69	0.62	—
	2.76	0.00	0.00	—
	3.44	0.69	0.62	—
	0.64	0.17	0.12	—
	2.78	0.52	0.50	—
	11.04	2.04	1.97	—
Key metrics
	3.63	0.90	0.79	—
	60.80%	14.70%	12.10%	—
	46.57%	8.50%	7.70%	—
	—	7.40%	6.80%	—
	1.53%	-6.00%	—	—
	504.35%	4.00%	—	—
	—	2.54	-1.71	—
	—	4.88	-2.90	—
	—	0.04	0.07	—
	—	-0.31	-1.76	—
	—	68.9	50.3	—
Balance sheet
	—	12.78	11.82	—
	—	10.08	9.02	—
	—	0.70	2.40	—
	—	0.84	0.66	—
	—	0.70	0.78	—
	—	—	0.00	—
	—	1.54	1.70	—
	—	0.38	0.54	—
	—	2.74	2.16	—
	—	0.39	0.64	—
	—	0.39	0.64	—
	—	0.00	0.00	—
	—	10.04	9.47	—
Cash flow
	—	2.54	-1.45	—
	—	0.48	0.05	—
	—	-0.05	-0.04	—
	—	0.00	0.26	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +1.53%
Profit YoY (TTM): +504.35%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 50.71%

Quarter	September 2026	June 2026
Promoter %	50.71%	50.71%

Holder	Type	Holding	Previous	Change
VIJAYA MANI	Promoter	34.56%	34.56%	0.00%
PADAM DUGAR	Public	12.54%	12.54%	0.00%
ANNJANA DUGAR	Public	1.59%	1.59%	0.00%
DIPAKBHAI HARIBHAI GAUDANI	Public	1.31%	1.31%	0.00%
RASILABEN DIPAKBHAI GAUDANI	Public	1.25%	1.25%	0.00%
MANUBHAI M PATEL	Promoter Group	0.24%	0.24%	0.00%
USHA H MEHTA	Promoter Group	0.20%	0.20%	0.00%
HARENDRA A MEHTA	Promoter Group	0.20%	0.20%	0.00%
SHEETAL J SHAH	Promoter Group	0.16%	0.16%	0.00%
SHYAM SINGH TRIPATHI	Promoter Group	0.12%	0.12%	0.00%
BINOY MUKERJEE	Promoter Group	0.12%	0.12%	0.00%
M VENUGOPAL	Promoter Group	0.12%	0.12%	0.00%
P. NAGESHWAR RAO	Promoter Group	0.12%	0.12%	0.00%
V. K. JAIN	Promoter Group	0.12%	0.12%	0.00%
Y.P. TRIBHUVAN	Promoter Group	0.12%	0.12%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Colinz Laboratories ltd. S	17	69.00	6.24	7.40%	+1.53% TTM	+504.35% TTM	+56.00%

Filings & corporate actions

Recent announcements

Dear sir, Please find the attached News Paper Publication as required under Regulation 47(3) of SEBI(LODR), 2015. for the Quarter and Half year ended on 30-9-2026. Kindly take the same ....31 Oct 2026 · Company Update / Newspaper Publication
The Attached Results for Quarter ended on 30-9-2026 was approved in Bopard Meeting held on 29-10-2026 as required under Regulation 30 and 33 and our Auditors have issued Limited Review ....29 Oct 2026 · Result / Financial Results
We would like to inform you that, the Board of Directors of the Company at their meeting held today i.e. 29th October, 2026 has, inter alia considered and approved Unaudited Financial Results ....29 Oct 2026 · Board Meeting / Outcome of Board Meeting
Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve We wish to inform you that ....19 Oct 2026 · Board Meeting / Board Meeting
Dear Sir, PFA, The Compliance Certificate issued by our RTA for Sep-26 under regulation 74(5). Kindly take the same on records . For Colinz Labs Ltd Director7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir, PFA, attached Certificate under Regulation 32 of SEBI(LODR) Regulation,2015 and Statement of Deviation or Variation is NOT applicable to the Company for the Quarter Ended on ....1 Oct 2026 · Company Update / General
Dear Sir, Pursuant to Regulations23(9) of SEBI (LODR). Regulations,2015, the said Regulation is not applicable to us, Kindly take the Non-Applicability Certificate on records for Quarter ....1 Oct 2026 · Company Update / General
We would like to inform you that pursuant to the COmpanys Act and SEBI(PIT), Regulation, 2015 The Trading Window for Designated Persons and KMPS will remain closed form 1-10-26 to till ....29 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please find enclosed herewith the Srutinizers Report for our 40th AGM held on 22-09-2026 issued todted dated 23-09-2026. Kindly take the same on records. For Colinz Labs Ltd Director23 Sep 2026 · AGM/EGM / AGM
DEAR SIR SUMMERY OF OF 40TH AGM HELD ON 22-09-2026 AT 2.30 PM . KINDLY TAKE THE SAME ON RECORDS FOR COLINZ LABORATORIES LTD VIJAYA MANI CHAIRPESRSON OF THE MEETING22 Sep 2026 · AGM/EGM / AGM
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post Offer Advertisement under Regulation 18(12) of The Securities and Exchange Board of India ....4 Sep 2026 · Company Update / General
Dear Sir, Pursuant to Regualtion 47 of SEBI(LODR) Regulations, 2015 we ahereby enclosed News Papar Cliping of our 40 th AGM Ads given in the Paper on 27-08-2026. Kindly take the same ....27 Aug 2026 · Company Update / Newspaper Publication
Dear Sir, Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....20 Aug 2026 · Others / Reg. 34 (1) Annual Report
Dear Sir, AS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book from 15-09-2026 to 22-09-2026 for the purpose ....20 Aug 2026 · Corp. Action / Book Closure
As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....20 Aug 2026 · AGM/EGM / AGM
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories ....12 Aug 2026 · Company Update / Open Offer
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....6 Aug 2026 · Company Update / Open Offer
Dear Sir, Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and ....5 Aug 2026 · Company Update / Newspaper Publication
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....31 Jul 2026 · Company Update / General
Dear Sir, As required under SEBI(LODR), Regulation, 2015, we are submitting herewith the News Paper Publication , published on 31-7-2026 for the Quarter Ended 30-6-2026. Kindly take ....31 Jul 2026 · Company Update / Newspaper Publication
Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.30 Jul 2026 · Result / Financial Results
1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) ....30 Jul 2026 · Board Meeting / Outcome of Board Meeting
Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve This is to inform the exchange ....18 Jul 2026 · Board Meeting / Board Meeting
Dear Sir, As required under under SEBI Regulation 2015, Please find the attached intimation towards closure of Trading form 1-7-2026 till the 48 hours of the Issue of Quarterly results ....14 Jul 2026 · Insider Trading / SAST / Closure of Trading Window
Dear Sir, Please find the attached Certificate issued by our RTA Bigshare Services Pvt Ltd. for the Quarter ended on 30-6-2026 as required under regulation 74(5). Kindly tahe the ....7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer ("DLOF") for the attention of the Public Shareholders of Colinz Laboratories ....4 Jul 2026 · Company Update / General
Dear Sir, Please find the attached Certificate from our PCA towards Non-Applicability of Corporate Governence as required under 15(2) of SEBI LODR, 2015. Kindly take the same on records. For ....3 Jul 2026 · Company Update / General
Dear Sir, Please find the attached Disclosure as required under Regulation 32 of SEBI (LODR), 2015 for the Quarter Ended on june-26. Kindly take the same on records . For Colinz Labs ....3 Jul 2026 · Company Update / General
Please find the attached Disclosure towards NOn-Applicability of Related Party Transactions as per SEBI Regulation 23(9) for LODR, 2015. for the Quarter Ended on June-26. Kindly take ....3 Jul 2026 · Company Update / General
Dear Sirs, This has reference to the above captioned subject , we are submitting herewith the Discloure under Regulation 30 as amnded from time to time The Completion of our Factory ....27 Jun 2026 · Company Update / General
Saffron Capital Advisors Private Limited ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1) and 4 read with Regulations 13(4), ....27 Jun 2026 · Company Update / General
Please the attached disclosure under regularion 30 and 30A of SEBI (LODR) Regulation 2015. towards Sales of Promoter Shares. The details informatiom is attahced in the below attachement. ....18 Jun 2026 · Company Update / Open Offer - Updates
Saffron Capital Advisors Private Limited ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 ead with Regulations 13, 14 and 15(1) of ....18 Jun 2026 · Company Update / Open Offer
This has reference to your mail asking clarification on 01-06-2026. Please find our reply and also clarification for significant movment in our share price in this month. Kindly ccept ....11 Jun 2026 · Company Update / General
The Exchange has sought clarification from Colinz Laboratories Ltd on June 1, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....1 Jun 2026 · Company Update / Clarification
Dear Sir, Submitting herewith the Disclosure 29(1) as required under SEBI (SAST) Regulations, 2011 submitted by Mr Padam Dugar the acquirer . Kindly take the same on records. For ....26 May 2026 · Company Update / General
Dear Sir, Submitting the Dislosure under Regulatiom 29(2) under SEBI (SAST) Regulation 2011. Sumitted by Vijaya Mani the Promoter and Director of the Company anaingt sell of her Equity ....26 May 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padam Dugar & Others25 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vijaya Mani25 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padam Dugar & Others25 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Board meetings

29 Oct 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results